ES519982A0 - Procedimiento para preparar -monohidrato de (+)-catequina. - Google Patents

Procedimiento para preparar -monohidrato de (+)-catequina.

Info

Publication number
ES519982A0
ES519982A0 ES519982A ES519982A ES519982A0 ES 519982 A0 ES519982 A0 ES 519982A0 ES 519982 A ES519982 A ES 519982A ES 519982 A ES519982 A ES 519982A ES 519982 A0 ES519982 A0 ES 519982A0
Authority
ES
Spain
Prior art keywords
monohydrate
catequine
prepare
procedure
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES519982A
Other languages
English (en)
Other versions
ES8504977A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Consumer Healthcare SARL
Original Assignee
Zyma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma SA filed Critical Zyma SA
Publication of ES8504977A1 publication Critical patent/ES8504977A1/es
Publication of ES519982A0 publication Critical patent/ES519982A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES519982A 1982-02-24 1983-02-22 Procedimiento para preparar -monohidrato de (+)-catequina. Granted ES519982A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8205453 1982-02-24

Publications (2)

Publication Number Publication Date
ES8504977A1 ES8504977A1 (es) 1985-04-16
ES519982A0 true ES519982A0 (es) 1985-04-16

Family

ID=10528576

Family Applications (1)

Application Number Title Priority Date Filing Date
ES519982A Granted ES519982A0 (es) 1982-02-24 1983-02-22 Procedimiento para preparar -monohidrato de (+)-catequina.

Country Status (30)

Country Link
US (1) US4515804A (es)
EP (1) EP0087164B1 (es)
JP (1) JPS58185578A (es)
KR (1) KR900006557B1 (es)
AT (2) ATE27456T1 (es)
AU (1) AU566685B2 (es)
BE (1) BE895991A (es)
CA (1) CA1212381A (es)
CH (1) CH654004A5 (es)
DD (1) DD208613A5 (es)
DE (2) DE3306092A1 (es)
DK (1) DK80983A (es)
ES (1) ES519982A0 (es)
FI (1) FI76330C (es)
FR (1) FR2521995A1 (es)
GB (1) GB2115409B (es)
GR (1) GR77918B (es)
HU (1) HU194854B (es)
IL (1) IL67969A (es)
IN (1) IN157218B (es)
IT (1) IT1197582B (es)
LU (1) LU84657A1 (es)
NL (1) NL8300600A (es)
NO (1) NO830629L (es)
NZ (1) NZ203369A (es)
PH (1) PH20689A (es)
PL (1) PL141809B1 (es)
PT (1) PT76279B (es)
SE (1) SE8300974L (es)
ZA (1) ZA831216B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219384A (ja) * 1983-05-30 1984-12-10 Mitsui Norin Kk 天然抗酸化剤の製造方法
JPS6013780A (ja) * 1983-07-05 1985-01-24 Mitsui Norin Kk 茶カテキン類の製造方法
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
EP0263132A4 (en) * 1986-04-07 1988-11-16 Clemetson Ab Charles ASCORBIC ACID COATED WITH CATECHIN AND METHOD.
DE4316347C1 (de) * 1993-02-26 1994-08-18 Ina Dr Levi Verfahren zur Herstellung einer pharmazeutischen Zubereitung und Verwendung derselben zur Behandlung bestimmter Erkrankungen
WO1994022322A1 (en) * 1993-04-01 1994-10-13 Kalamazoo Holdings, Inc. Solid microcrystalline green tea catechin antioxidants for lipids
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) * 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
EP2108370A1 (en) 2002-04-30 2009-10-14 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US20040220119A1 (en) * 2003-04-04 2004-11-04 Unigen Pharmaceuticals, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
KR100545304B1 (ko) * 2004-09-01 2006-05-08 주식회사 유니젠 아선약을 포함하는 운카리아 속 식물, 또는 이의 황금및/또는 녹차의 배합물을 포함하는 사이클로옥시게나제및/또는 5-리폭시게나제 억제용 조성물
CN103833713B (zh) * 2008-11-28 2016-02-03 中国医学科学院药物研究所 硝克柳胺化合物晶iii型、其制法和其药物组合物与用途
US11974982B2 (en) 2020-04-03 2024-05-07 The Board Of Trustees Of The University Of Illinois Stimulus-responsive antioxidant crystals and method for their preparation

Also Published As

Publication number Publication date
ATA62083A (de) 1986-10-15
AU566685B2 (en) 1987-10-29
PH20689A (en) 1987-03-24
FR2521995B1 (es) 1984-09-07
IL67969A0 (en) 1983-06-15
PL240734A1 (en) 1984-11-08
AT383123B (de) 1987-05-25
BE895991A (fr) 1983-08-23
FI830571L (fi) 1983-08-25
NZ203369A (en) 1986-03-14
PL141809B1 (en) 1987-08-31
US4515804A (en) 1985-05-07
DE3371785D1 (en) 1987-07-02
FI830571A0 (fi) 1983-02-21
LU84657A1 (de) 1983-09-08
KR900006557B1 (ko) 1990-09-13
NL8300600A (nl) 1983-09-16
ATE27456T1 (de) 1987-06-15
ES8504977A1 (es) 1985-04-16
SE8300974D0 (sv) 1983-02-22
DK80983D0 (da) 1983-02-23
CH654004A5 (de) 1986-01-31
GB8302562D0 (en) 1983-03-02
PT76279A (en) 1983-03-01
EP0087164B1 (en) 1987-05-27
GB2115409A (en) 1983-09-07
CA1212381A (en) 1986-10-07
JPS58185578A (ja) 1983-10-29
KR840003625A (ko) 1984-09-15
GB2115409B (en) 1985-08-07
SE8300974L (sv) 1983-08-25
EP0087164A1 (en) 1983-08-31
IN157218B (es) 1986-02-15
HU194854B (en) 1988-03-28
JPH032154B2 (es) 1991-01-14
GR77918B (es) 1984-09-25
DK80983A (da) 1983-08-25
DE3306092A1 (de) 1983-09-01
IT8347760A0 (it) 1983-02-22
PT76279B (en) 1986-03-19
IL67969A (en) 1986-11-30
IT1197582B (it) 1988-12-06
DD208613A5 (de) 1984-04-04
ZA831216B (en) 1985-03-27
FR2521995A1 (fr) 1983-08-26
NO830629L (no) 1983-08-25
FI76330B (fi) 1988-06-30
FI76330C (fi) 1988-10-10
AU1178583A (en) 1983-09-01

Similar Documents

Publication Publication Date Title
ES519982A0 (es) Procedimiento para preparar -monohidrato de (+)-catequina.
MX6314E (es) Procedimiento microbiologico para la preparacion de monacolin k
DK173883D0 (da) Substituerede 8-phenylxanthiner
MX6618E (es) Procedimiento para la preparacion de derivados de azetidina
ES529774A0 (es) Procedimiento para la produccion de derivados de 1-sulfo-2-oxoacetidina
ES546625A0 (es) Procedimiento para la sintesis de derivados de acidos omega-aminados
FI891986A0 (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
ES506337A0 (es) Procedimiento para la preparacion de derivados de guanidina
ES2051766T3 (es) Antigestagenos para la inhibicion de la sintesis uterina de prostaglandinas.
MX9300436A (es) Composicion farmaceutica para estimular el sistema inmune.
ES500959A0 (es) Procedimiento para la preparacion de derivados de cianoal- quil-fenilurea
MX6514E (es) Procedimiento para la preparacion de compuestos derivados hidroxi de 2-isopropilaminopirimidina
ES526451A0 (es) Procedimiento para la preparacion de derivados de acidos 2-fenoxi-propionicos de pentitas
IT8068679A0 (it) Procedimento per il rinverdimento di pelli da pelliccia
MX6943E (es) Procedimiento para preparar ureidobencilpenicilinas alfa-substituidas
ES2034017T3 (es) Procedimiento para la obtencion de 3-fenil-2-estril-pirrolidinas.
AR218841A1 (es) Procedimiento para la mejora de las propiedades de proteinas brutas de origen animal
ES2037116T3 (es) Procedimiento para la obtencion de bencilaminoarildihidropiridinlactonas.
ES526448A0 (es) Procedimiento para la preparacion de derivados de acidos 5-fenoxibenzoicos de pentitas
MX6356E (es) Procedimiento para la preparacion de derivados ciclohexilcarboxilicos
MX155541A (es) Procedimiento para la produccion de derivados de 1-azolil-2-aril-3-fluoro-alcan-2-ol